Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma
10.1002/cncr.27758
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
2014
|
| Subjects: | |
| Online Access: | http://scholarbank.nus.edu.sg/handle/10635/116518 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-116518 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-1165182024-11-08T19:38:30Z Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma Toh, H.C. Chen, P.-J. Carr, B.I. Knox, J.J. Gill, S. Ansell, P. McKeegan, E.M. Dowell, B. Pedersen, M. Qin, Q. Qian, J. Scappaticci, F.A. Ricker, J.L. Carlson, D.M. Yong, W.P. CANCER SCIENCE INSTITUTE OF SINGAPORE angiogenesis hepatocellular carcinoma (HCC) linifanib platelet-derived growth factor receptor (PDGFR) sorafenib vascular endothelial growth factor receptor (VEGFR) 10.1002/cncr.27758 Cancer 119 2 380-387 CANCA 2014-12-12T07:50:50Z 2014-12-12T07:50:50Z 2013-01-15 Article Toh, H.C., Chen, P.-J., Carr, B.I., Knox, J.J., Gill, S., Ansell, P., McKeegan, E.M., Dowell, B., Pedersen, M., Qin, Q., Qian, J., Scappaticci, F.A., Ricker, J.L., Carlson, D.M., Yong, W.P. (2013-01-15). Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma. Cancer 119 (2) : 380-387. ScholarBank@NUS Repository. https://doi.org/10.1002/cncr.27758 0008543X http://scholarbank.nus.edu.sg/handle/10635/116518 000313365500019 Scopus |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| topic |
angiogenesis hepatocellular carcinoma (HCC) linifanib platelet-derived growth factor receptor (PDGFR) sorafenib vascular endothelial growth factor receptor (VEGFR) |
| spellingShingle |
angiogenesis hepatocellular carcinoma (HCC) linifanib platelet-derived growth factor receptor (PDGFR) sorafenib vascular endothelial growth factor receptor (VEGFR) Toh, H.C. Chen, P.-J. Carr, B.I. Knox, J.J. Gill, S. Ansell, P. McKeegan, E.M. Dowell, B. Pedersen, M. Qin, Q. Qian, J. Scappaticci, F.A. Ricker, J.L. Carlson, D.M. Yong, W.P. Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma |
| description |
10.1002/cncr.27758 |
| author2 |
CANCER SCIENCE INSTITUTE OF SINGAPORE |
| author_facet |
CANCER SCIENCE INSTITUTE OF SINGAPORE Toh, H.C. Chen, P.-J. Carr, B.I. Knox, J.J. Gill, S. Ansell, P. McKeegan, E.M. Dowell, B. Pedersen, M. Qin, Q. Qian, J. Scappaticci, F.A. Ricker, J.L. Carlson, D.M. Yong, W.P. |
| format |
Article |
| author |
Toh, H.C. Chen, P.-J. Carr, B.I. Knox, J.J. Gill, S. Ansell, P. McKeegan, E.M. Dowell, B. Pedersen, M. Qin, Q. Qian, J. Scappaticci, F.A. Ricker, J.L. Carlson, D.M. Yong, W.P. |
| author_sort |
Toh, H.C. |
| title |
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma |
| title_short |
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma |
| title_full |
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma |
| title_fullStr |
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma |
| title_full_unstemmed |
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma |
| title_sort |
phase 2 trial of linifanib (abt-869) in patients with unresectable or metastatic hepatocellular carcinoma |
| publishDate |
2014 |
| url |
http://scholarbank.nus.edu.sg/handle/10635/116518 |
| _version_ |
1821187393759215616 |